Featured Research

from universities, journals, and other organizations

Smart-bombing cancer, Alzheimer's disease, and more

Date:
March 14, 2013
Source:
University of South Carolina
Summary:
Scientists are crafting new pharmaceuticals that could dramatically improve a patient’s odds when heavy-duty drugs are prescribed. The research is focused on developing drugs with the kind of precision that the military seeks with smart bombs.

In the military, collateral damage means innocent civilians dying. In medicine, it means side effects -- and that can mean death for the patient.

But Peisheng Xu of the University of South Carolina is helping craft new pharmaceuticals that could dramatically improve a patient's odds when heavy-duty drugs are prescribed. Xu's research is focused on developing drugs with the kind of precision that the military seeks with smart bombs.

Xu's team is perfecting drugs with two molecular parts -- one that functions as a guiding mechanism, and the other as a warhead. When it comes to cancer, for example, the drugs are designed to move through the human body rather innocuously, ignoring the many good cells that make up a healthy human body.

But things quickly change when one of these two-headed drugs finds a bad guy. The drug enters the offending cell and unloads the pharmaceutical warhead, serving up a cellular annihilation that tumor cells so richly deserve.

One beauty of the approach is that many molecular warheads have already been developed.

"Lots of drugs are very effective in killing cancer cells, but when they kill cancer cells, they also kill healthy cells, or damage healthy cells," said Xu, a researcher in the South Carolina College of Pharmacy. "Doxorubicin, for example, is a very powerful anticancer drug, but it will also cause heart damage -- a patient can only use a certain amount of that drug over a lifetime, otherwise the patient will have heart problems."

A polymer chemist, Xu leads a team of scientists that crafts a polymer coating, or carrier, for a drug like doxorubicin. The coating encapsulates the powerful anticancer agent, rendering it harmless until released. The polymer coating also has design features that help the drug find a tumor cell, work its way inside it, and only then release the anticancer cargo.

"The carrier I'm using is a nanoparticle," Xu said. "It has a size about 1,000 times smaller than the diameter of a human hair."

Working with colleagues Remant K.C. and Bindu Thapa at USC, Xu published a paper in Molecular Pharmaceutics (released online Aug. 9, 2012) detailing a nanoparticle polymer containing a 2-(pyridin-2-yldisulfanyl) side chain that reliably releases a doxorubicin cargo after moving from an extracellular environment to an intracellular one. The polymer also has other molecular "handles" to which the chemists can attach cellular targeting moieties.

Xu and K.C. followed up with a paper in the Dec. 18, 2012 issue of Advanced Materials that shows how to use both doxorubicin and paclitaxel to provide a "cocktail therapy" option with their drugs, achieving a strong synergistic effect. The American Association of Colleges of Pharmacy has taken notice, awarding Xu a highly competitive New Investigator Award in 2012.

And it's not just cancer that Xu has his eye on. "We're trying to extend the work into other areas as well, such as diseases of the central nervous system -- Alzheimer's disease -- and liver disease," he said. "We've also just begun a collaboration involving cardiovascular disease. The goal of my research is to give the patient the right drug, to the right tissue, to the right cell, in the right dose, at the right time."


Story Source:

The above story is based on materials provided by University of South Carolina. Note: Materials may be edited for content and length.


Journal References:

  1. Remant Bahadur K. C., Peisheng Xu. Multicompartment Intracellular Self-Expanding Nanogel for Targeted Delivery of Drug Cocktail. Advanced Materials, 2012; 24 (48): 6479 DOI: 10.1002/adma.201202687
  2. Remant Bahadur K. C., Bindu Thapa, Peisheng Xu. pH and Redox Dual Responsive Nanoparticle for Nuclear Targeted Drug Delivery. Molecular Pharmaceutics, 2012; 9 (9): 2719 DOI: 10.1021/mp300274g

Cite This Page:

University of South Carolina. "Smart-bombing cancer, Alzheimer's disease, and more." ScienceDaily. ScienceDaily, 14 March 2013. <www.sciencedaily.com/releases/2013/03/130314144214.htm>.
University of South Carolina. (2013, March 14). Smart-bombing cancer, Alzheimer's disease, and more. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2013/03/130314144214.htm
University of South Carolina. "Smart-bombing cancer, Alzheimer's disease, and more." ScienceDaily. www.sciencedaily.com/releases/2013/03/130314144214.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins